Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer

Affiliations

• ¹ Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
• ² Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• ³ Pritzker School of Molecular Engineering, Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois, USA.
• ⁴ Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.
• ⁵ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.